Zai Lab Limited (NASDAQ:ZLAB)’s traded shares stood at 1.05 million during the last session, with the company’s beta value hitting 1.19. At the close of trading, the stock’s price was $34.27, to imply an increase of 7.09% or $2.27 in intraday trading. The ZLAB share’s 52-week high remains $53.95, putting it -57.43% down since that peak but still an impressive 38.78% since price per share fell to its 52-week low of $20.98. The company has a valuation of $3.75B, with an average of 0.75 million shares in intraday trading volume over the past 10 days and average of 743.44K shares over the past 3 months.
Analysts have given a consensus recommendation of a Buy for Zai Lab Limited (ZLAB), translating to a mean rating of 1.50. Of 15 analyst(s) looking at the stock, 1 analyst(s) give ZLAB a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 13 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$1.24.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Zai Lab Limited (NASDAQ:ZLAB) trade information
After registering a 7.09% upside in the last session, Zai Lab Limited (ZLAB) has traded red over the past five days. The stock hit a weekly high of 35.00 this Thursday, 03/16/23, jumping 7.09% in its intraday price action. The 5-day price performance for the stock is -0.20%, and -9.79% over 30 days. With these gigs, the year-to-date price performance is 11.63%. Short interest in Zai Lab Limited (NASDAQ:ZLAB) saw shorts transact 2.89 million shares and set a 2.62 days time to cover.
Analysts on Wall Street suggest a consensus price target of $74.02, implying an increase of 53.7% to the stock’s current value. The extremes give us $25.00 and $138.00 for target low and target high price respectively. As such, ZLAB has been trading -302.68% off suggested target high and 27.05% from its likely low.
Zai Lab Limited (ZLAB) estimates and forecasts
Looking at statistics comparing Zai Lab Limited share performance against respective industry, we note that the company has outperformed competitors. Zai Lab Limited (ZLAB) shares are -30.30% down over the last 6 months, with its year-to-date growth rate higher than industry average at 13.82% against 9.40%. Revenue is forecast to shrink -22.80% this quarter before jumping 48.80% for the next one. The rating firms project that company’s revenue will grow 47.50% compared to the previous financial year.
Revenue forecast for the current quarter as set by 5 analysts is $54.98 million. Meanwhile, for the quarter ending Dec 2022, a total of 4 analyst(s) estimate revenue growth to $62.25 million.Earnings reports from the last fiscal year show that sales brought in $43.1 million and $44.17 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 27.60% before jumping 40.90% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 14.20% for the past 5-year period. While 2023 is set for a 38.90% return in earnings, projections for the next 5 years are at 30.00% annually.
Zai Lab Limited has its next earnings report out between May 08 and May 14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Zai Lab Limited has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Zai Lab Limited (NASDAQ:ZLAB)’s Major holders
Zai Lab Limited insiders hold 0.09% of total outstanding shares, with institutional holders owning 71.58% of the shares at 71.65% float percentage. In total, 71.58% institutions holds shares in the company, led by Invesco Ltd. As of Sep 29, 2022, the company held over 8.33 million shares (or 8.50% of shares), all amounting to roughly $284.75 million.
The next major institution holding the largest number of shares is FMR, LLC with 4.71 million shares, or about 4.81% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $160.98 million.
We also have Fidelity Emerging Markets Fund (US) and Vanguard International Stock Index-Emerging Markets Stk as the top two Mutual Funds with the largest holdings of the Zai Lab Limited (ZLAB) shares. Going by data provided on Nov 29, 2022, Fidelity Emerging Markets Fund (US) holds roughly 1.3 million shares. This is just over 1.33% of the total shares, with a market valuation of $50.04 million. Data from the same date shows that the other fund manager holds a little less at 1.27 million, or 1.29% of the shares, all valued at about 28.19 million.